These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32997434)

  • 21. Vascularised composite allotransplantation in solid organ transplant recipients: A systematic review.
    Honeyman C; Stark HL; Fries CA; Gorantla VS; Davis MR; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):316-326. PubMed ID: 33036926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody immunosuppressive therapy in solid organ transplant: Part II.
    Klipa D; Mahmud N; Ahsan N
    MAbs; 2010; 2(6):607-12. PubMed ID: 20948291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal of immunosuppression: implications for composite tissue allograft transplantation.
    Hricik DE
    Transplant Proc; 1998 Sep; 30(6):2721-3. PubMed ID: 9745554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Microbiome and Immune Regulation After Transplantation.
    Tabibian JH; Kenderian SS
    Transplantation; 2017 Jan; 101(1):56-62. PubMed ID: 27517729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gut microbiome: a clinically significant player in transplantation?
    Vindigni SM; Surawicz CM
    Expert Rev Clin Immunol; 2015; 11(7):781-3. PubMed ID: 26065325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Dufresne SF; Boucher A; Jevnikar A; Prasad GVR; Shoker A; Kabbani D; Hebert MJ; Cardinal H; Houde I; Humar A; Kumar D
    Clin Infect Dis; 2019 Apr; 68(8):1320-1326. PubMed ID: 30107568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of immunosuppressive agents for solid organ transplantation in children.
    Coelho T; Tredger M; Dhawan A
    Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-targeted therapy for the management of solid organ transplant recipients.
    Szczepanik A; Iasella CJ; McDyer JF; Ensor CR
    Hum Immunol; 2019 Mar; 80(3):184-190. PubMed ID: 30562564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic Effects of the Microbiota in Organ Transplantation.
    Rey K; Choy JC
    Clin Lab Med; 2019 Mar; 39(1):185-195. PubMed ID: 30709506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation.
    Reinders ME; Rabelink TJ; de Fijter JW
    Curr Opin Organ Transplant; 2013 Feb; 18(1):44-50. PubMed ID: 23254697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving immunosuppressive regimens for lung transplant recipients.
    Meyer NJ; Bhorade SM
    Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota and its implications in small bowel transplantation.
    Wang C; Li Q; Li J
    Front Med; 2018 Jun; 12(3):239-248. PubMed ID: 29524068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bad and the Good News on Cancer Immunotherapy: Implications for Organ Transplant Recipients.
    Maggiore U; Pascual J
    Adv Chronic Kidney Dis; 2016 Sep; 23(5):312-316. PubMed ID: 27742386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of an Altered Gut Microbiome in Rat Experimental Vascularized Composite Transplantation.
    Shah AM; Aral AM; Barclay DA; Yin J; Zamora R; Gorantla V; Vodovotz Y
    Exp Clin Transplant; 2024 Feb; 22(2):137-147. PubMed ID: 38511984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut microbiome in end-stage lung disease and lung transplantation.
    Zhang S; Swarte JC; Gacesa R; Knobbe TJ; Kremer D; Jansen BH; de Borst MH; ; Harmsen HJM; Erasmus ME; Verschuuren EAM; Bakker SJL; Gan CT; Weersma RK; Björk JR
    mSystems; 2024 Jun; 9(6):e0131223. PubMed ID: 38712927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
    Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
    Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
    Bhat M; Watt KD
    Clin Transplant; 2015 Jul; 29(7):654-63. PubMed ID: 26094583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the Microbiome Affect the Outcome of Renal Transplantation?
    Campbell PM; Humphreys GJ; Summers AM; Konkel JE; Knight CG; Augustine T; McBain AJ
    Front Cell Infect Microbiol; 2020; 10():558644. PubMed ID: 33425774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.